“Neuropathy” Is a Category, Not a Diagnosis: What Nerve Testing Actually Measures

What this video covers

• What nerve conduction studies and needle electromyography really measure, and how they differ
• How slowed conduction points to a damaged myelin sheath, while lower amplitude points to axon loss
• How testing tells a pinched nerve root in the spine apart from carpal tunnel syndrome or a plexus injury
• Why large fiber testing can be fully normal in small fiber neuropathy, and what is used instead
• How diabetes and metabolic disease change the nerve picture, and where glucose control truly helps
• When testing is truly needed, when it is not needed at all, and what the risks of the needle study are
• MEDICAL DISCLAIMER: This content is for educational purposes only and is not medical advice. It does not substitute for professional diagnosis or treatment. Always consult a licensed healthcare provider regarding your condition. Viewing this video does not establish a doctor-patient relationship.

A nerve conduction study measures time and size. Slowed conduction means damaged myelin. Lower amplitude means axon loss. Needle EMG listens to the muscle itself for the spontaneous firing (firing on its own) of a muscle that has lost its nerve. Together they tell a pinched spinal nerve root apart from carpal tunnel syndrome or a plexus injury.

You wake at three in the morning with your hand dead. You shake it over the edge of the bed until feeling crawls back in. By autumn your feet burn as if the sheets were packed with hot sand. Somewhere in your chart, someone has written the word neuropathy — and nobody has measured anything.

That word is not a diagnosis. It is a category. This article explains what a nerve conduction study and a needle electromyogram really measure. It explains why very different problems can feel the same from the inside. It covers what these tests cannot see, and when the evidence says testing is worth doing at all.

“Neuropathy” is a category, not a diagnosis

A nerve root squeezed in your lower spine. A median nerve choked at the wrist. A brachial plexus stretched at the shoulder. Small fibers dying quietly in the skin of your feet. All of them cause numbness and burning. Only one of them is helped by an epidural. Each one runs a different course over time, and none of that can be read off the word in your chart.

Dr. Gurpreet Singh Padda, MD, MBA, MHP, puts the problem plainly. In a fifteen-minute visit, the incentive is to name the symptom and turn the room over. Naming is fast. Measuring is slow. Patients pay the difference in years.

What does a nerve conduction study measure?

A peripheral nerve is not a wire. It is a cable of axons (nerve fibers), and the large ones are wrapped in myelin — a fatty sleeve of insulation laid down by Schwann cells, broken at intervals by bare gaps. The signal does not crawl along the fiber. It jumps, gap to gap. That is why a healthy large fiber carries signals fast.

A nerve conduction study (NCS) puts a stimulating electrode over the nerve and a recording electrode farther down. It sends a brief electrical pulse and measures two things directly:

• Time — the latency from stimulus to response, and the conduction velocity over a measured distance.
• Size — the amplitude of the response, for both feeling and movement.

Those two numbers separate two very different diseases.

Slow means insulation

When myelin is damaged, the signal loses its ability to jump. Latency gets longer, velocity falls, and the signal arrives late. That is compressive demyelination, and carpal tunnel syndrome is the textbook example. The median nerve slows right across the wrist. The same nerve carries signals normally in the forearm above it, and normally again in the palm beyond it.

Small means wiring

When the axon itself dies, timing can look nearly normal. That is because the fibers that are left still carry signals at full speed. There are just fewer of them left to answer, so the amplitude collapses.

The late responses reach where the distal study cannot

The F wave and the H reflex time a signal sent up to the spinal cord and back. They test the long upper stretch of nerve nearest the nerve root. The study lower down never reaches that part.

What does an EMG test show?

The conduction study tells the physician about the cable. Electromyography (EMG) — the needle exam — tells the physician what the cable is running.

A fine recording needle goes into selected muscles. The physician listens to their electrical activity, literally, on a speaker, at rest and during effort. Healthy muscle at rest is electrically silent. Muscle that has lost its nerve is not. It fires on its own, single fibers going off with no nerve left to command them. That is the sound of denervation (a muscle cut off from its nerve).

Two practical points follow:

1. Timing matters. This spontaneous firing takes weeks to show up after an injury. That is why a study done too early can be falsely reassuring.
2. EMG is a localizing study, not a screening test. Every muscle is supplied by one nerve, from one branch of the plexus, from one nerve root. The physician samples muscles that share a root but not a nerve. Then muscles that share a nerve but not a root. Then the paraspinal muscles (the muscles along the spine) fed by the root’s back branch. That places the damage on the map. Root. Plexus. Peripheral nerve.

Why do sciatica, carpal tunnel and diabetic neuropathy feel the same?

Sciatica, diabetic polyneuropathy, and carpal tunnel syndrome overlap almost completely in how they feel to you. They do not overlap at all in where they live.

That is the whole reason the symptom you feel cannot be trusted to show the location. Burning in the foot at night can come from small fibers dying in the skin. It can come from a root squeezed in the lower spine. Or it can come from a nerve trapped somewhere along its path in the limb. The feeling tells you something is wrong. It does not tell you where. Measurement does.

It also explains a common and crushing experience. An injection aimed at the wrong level or the wrong nerve cannot be expected to work. The injection did not fail. It was never aimed at your problem.

What the standard approach misses

Nothing here is a criticism of the physicians who treat nerve symptoms with medication. Symptom control has a real role. For many patients it is a reasonable part of care. What it does not do is answer the question of which nerve is injured, where, and how badly — and no amount of symptom control replaces that answer. Do not start, stop, or change any medication without consulting your physician.

But the honest fix is not more testing. It is less testing, aimed better. Electrodiagnostic testing earns its place by getting the diagnosis right, not by easing symptoms. Before a single electrode touches the skin, there should be a written question the study must answer. If no such question can be written, the study should not be run.

Two trusted sources anchor that position:

• A joint report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation (England and colleagues, Neurology, 2005) made three findings. Symptoms alone are fairly poor at predicting polyneuropathy. Signs found on exam predict better. And the most accurate definition combines multiple symptoms, multiple signs, and abnormal electrodiagnostic findings.[1]
• The American Diabetes Association position statement (Pop-Busui and colleagues, Diabetes Care, 2017) is blunter still. It says electrophysiological testing or referral to a neurologist is rarely needed for screening. It is saved for cases with unusual features — weakness worse than numbness, rapid onset, or one side worse than the other. It is also for cases where the diagnosis is unclear, or where a different cause is suspected.[2]

Say you have diabetes and the classic burning in both feet. A clinic that tests you by reflex is performing a ritual, not answering a question.

Can a nerve conduction study miss neuropathy?

Nerve conduction studies test large myelinated fibers only. The small fibers that carry burning, temperature, and pain are invisible to them.

So say you have furnace-hot feet at night, normal strength, normal reflexes, and a normal nerve conduction study. You have not been proven healthy. You have been proven to have intact large fibers. Those are not the same thing.

The validated test for small fiber neuropathy is a punch skin biopsy of the distal leg, which counts how many nerve fibers sit in the outer skin (intraepidermal nerve fibers). That comes from the joint European Federation of Neurological Societies and Peripheral Nerve Society guideline (Lauria and colleagues, European Journal of Neurology, 2010).[3] It is an established diagnostic test. It is separate from nerve conduction testing and adds to it.

What this means for your evaluation

If you are thinking about testing, three things are worth knowing before you agree to it.

First, the study should have a question. The fuller explanation of electrodiagnostic testing is on the electrodiagnostics and peripheral nerve evaluation page. The point of reading it is not to shop for a procedure. It is to show up able to ask what question your study is meant to answer.

Second, be honest about what testing costs you. Brief electrical pulses, a fine needle, and soreness and bruising afterward. Less common risks include bleeding or a hematoma (a pocket of blood) and local infection. When the needle study must sample chest wall or upper back paraspinal muscles, there is a rare risk of pneumothorax (a collapsed lung). Tell the physician beforehand if you take anticoagulants, have a bleeding disorder, have lymphedema in the limb, or carry an implanted cardiac device. Do not start, stop, or change any medication without consulting your physician — including blood thinners before a needle study.

Third, when the answer is metabolic, no needle placed in your spine will change it. Glucose control truly changes the disease, and the same ADA statement grades it honestly. It cut the relative risk of distal symmetric polyneuropathy by 78% in type 1 diabetes (Grade A evidence). In type 2 diabetes the cut was far smaller, 5–9% (Grade B).[2] That gap is real. It should shape what you expect, not be smoothed over.

Some add-ons come up in this space — low-carb nutrition, omega-3-derived pro-resolving mediators, red and near-infrared light therapy. These are unproven for the nerve injury itself. They are not standard care, and none of them replaces knowing which nerve is injured.

A composite illustration

The following is a composite — a picture built from many patients with this condition, not one person’s chart. It is here to show how the reasoning works, not as a typical outcome. Individual results vary.

An adult comes in after two years of burning feet. The right foot catches on stair edges. The chart says diabetic neuropathy. Two lumbar epidurals have been done, and neither helped. The exam finds equal loss of pinprick and vibration feeling in both feet, which fits the label. But it also finds weakness lifting and turning out the ankle on one side only. That does not fit. One-sided findings are exactly the unusual feature the ADA guideline says to test.[2]

Testing shows lower sensory amplitudes in both legs. That is axon loss that starts at the toes and works up, which fits the diagnosis on the chart. On top of it, the peroneal motor response slows sharply across the fibular head (the bony knob on the outside of the knee). Below that point it is normal. The needle exam finds denervation only in muscles supplied by that nerve, and the lower-back paraspinals are silent. That is not an L5 nerve root. That is a nerve trapped at the knee. The epidurals were aimed at a level that was never the problem.

What follows is not glamorous. Treat the trapped nerve, not the spine. Take pressure off the fibular head. Use a temporary ankle-foot brace while the nerve heals. And go hard at glucose control, because the metabolic neuropathy underneath is still there. None of it is fast. The foot drop improves over months, not weeks, because a regrowing axon moves at its own pace. The burning does not fully leave. It grows quieter over a year as glucose control tightens. That is a real result, not a cure.

If you have been told you have neuropathy and no one has measured a nerve, ask why not.

If your physician has ordered one, here is how to get ready for an EMG nerve test of the arm or an EMG nerve test of the leg.

Frequently asked questions

Addresses, hours and directions are listed on our Locations page.

Key takeaways

• A nerve conduction study measures two things — timing and size. Slow conduction points to damaged myelin insulation. Collapsed amplitude points to axon loss. Needle EMG then places the damage at a root, plexus, or peripheral nerve.
• Sciatica, diabetic polyneuropathy, and carpal tunnel feel almost the same but live in different places. That is why an injection aimed at the wrong level cannot be expected to work.
• Testing earns its place by getting the diagnosis right, not by easing symptoms. Symptoms alone predict polyneuropathy poorly. Signs predict better. Symptoms, signs, and electrodiagnostic findings together are most accurate.[1]
• Nerve conduction studies see only large fibers. A normal study with burning feet does not rule out small fiber neuropathy. For that, the validated test is a distal-leg skin biopsy that counts intraepidermal nerve fibers.[3]
• Say you carry the label “neuropathy” and no nerve has ever been measured. That is the talk to have next, most of all if a prior injection did not help or your findings are one-sided.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. To be evaluated at the Padda Institute Center for Interventional Pain Management, call (314) 481-5000 or text (314) 886-5902.

References

1. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64(2):199-207. PMID 15668414. PubMed
2. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Eur J Neurol. 2010;17(7):903-912, e44-e49. PMID 20642627. PubMed
3. Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154. PMID 27999003. PubMed

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP